🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, controlled, open-label, dose-exploration study to assess the ...
Status
Completed
Location
Tianjin Second People's Hospital
Start Date
2023-11-02
Trial ID
NCT06061536
Treatments Being Tested
Entecavir, 0.5 mg daily, will have clinical efficacy (assessed as an undete...
Status
Completed
Location
Local Institution
Start Date
2007-02
Trial ID
NCT00393484
Treatments Being Tested
The purpose of this study is to collect safety and tolerability data on tel...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01500616
Treatments Being Tested
Mother to child transmission(MTCT) is the main route of hepatitis B virus(H...
Status
Unknown
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02301650
Treatments Being Tested
The purpose of this study is to follow patients treated in entecavir Phase ...
Status
Completed
Location
Multiple Locations
Start Date
2003-02
Trial ID
NCT01337479
The purpose of this study was to determine the safety and anti-hepatitis B ...
Status
Completed
Location
Clinical Trial Site
Start Date
2002-02
Trial ID
NCT00034359
Treatments Being Tested
SHARE: Simple HAART with Abacavir, Reyataz, and Epivir...
Status
Unknown
Location
Whitman-Walker Clinic
Start Date
2006-08
Trial ID
NCT00426296
Treatments Being Tested
The purpose of this study is to see if cyclosporine, taken when a patient b...
Status
Completed
Location
University of California , Davis Medical Center
Start Date
TBD
Trial ID
NCT00031070
The study aims to evaluate the virological effectiveness of a third-line re...
Status
Unknown
Location
NCHADS
Start Date
2018-10-04
Trial ID
NCT03602690
Treatments Being Tested
The purpose of this study is to compare changes in HIV levels and certain i...
Status
Completed
Location
Michael S. Saag
Start Date
TBD
Trial ID
NCT00006443
Treatments Being Tested